Emma Shaw didn’t need to think twice about who she would nominate as one of our chosen charities because Queen Elizabeth Hospital Birmingham saved her mum’s life.
She said: “It was amazing what they did for her. She’d been on the waiting list for a liver transplant for almost two years with no result.
Then out of the blue she was offered the chance to take part in a special trial transplant scheme and the operation was a great success.
“I’ve no idea how much longer she would have had to wait for a transplant, but the family will be forever grateful that the Queen Elizabeth Hospital Birmingham chose her to take part in the trial scheme.”
The trial scheme Emma’s mum took part in was the NAPLES Trial in which ground-breaking new equipment is used to prolong the time surgeons have to transplant a donor organ.
Normally the liver would be packed in ice awaiting the transplant, but the procedure is very time critical before the organ becomes unusable.
In the new procedure special equipment is used to preserve the donor liver and its functions outside the body, thereby giving the surgical team much more time to complete the procedure.
Accepting our £390 donation to University Hospitals Birmingham Charity, Charlotte Schofield, Director of Fundraising, said: “On behalf of the amazing liver transplant team at the Queen Elizabeth Hospital Birmingham I would like to thank Emma and the staff at Gladstone Brookes for choosing to fundraise for our charity.
UHB Charity is proud to have funded, with the support of the Ann Fox Foundation, the liver perfusion machine which has made the NAPLES trial possible.
“The NAPLES trial is at the cutting-edge of modern medicine, and is helping to save lives right here in Birmingham.
The NAPLES project has given liver transplant patients, like Emma’s mum, a second chance of life.
This is a chance that they may not have had without this trial.
“The liver perfusion machine means that clinicians can cleanse a liver, removing any fatty deposits that may have built up there. This means that livers are not only kept alive outside the body, but they are transformed from marginal livers that may not be suitable for transplant, to organs that will give a patient another chance at life.
“We are so grateful to Gladstone Brookes for their fundraising efforts, which will help us to continue to fund this life-saving trial.”